Industry leaders to discuss AI in healthcare, cell and gene
therapy, market access and more at premier life sciences
event
LONDON, Sept. 18,
2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a
leading global provider of transformative intelligence, today
announced the full agenda for the 15th annual Clarivate
Pharmavision India conference. The 15th edition of
Pharmavision India reinforces the industry's dedication to patient
welfare, highlighting how collective efforts and innovative
strategies have transformed the healthcare ecosystem. With a focus
on improving patient outcomes and building resilience, the two-day
event will take place in Ahmedabad and Hyderabad on September
25-26, 2024.
In a country with billions of people, addressing challenges such
as healthcare affordability and access is crucial. Organizations
must adopt effective, patient-centric approaches across diverse
functions to ensure return on investment and a competitive
advantage. As the healthcare landscape evolves, balancing these
priorities is essential for sustainable growth and better patient
outcomes. Pharmavision India 2024 will provide attendees with the
opportunity to tackle the industry's most urgent challenges in life
sciences and healthcare.
Ramandeep Singh, Vice
President, Life Sciences and Healthcare, India, Clarivate, said: "Since its
inception in 2010, Pharmavision India has been a crucial platform
for the pharmaceutical, biotech, and healthcare sectors. It enables
industry leaders to align, strategize, and drive growth in a
competitive landscape. This event is pivotal for fostering
innovation across R&D, generics, biosimilars, and healthcare
manufacturing. Our expertise and leadership position us uniquely to
lead this conference, advancing industry standards and creating
collaboration opportunities."
Henry Levy, President, Life
Sciences and Healthcare, Clarivate, added: "At Clarivate,
our mission is to foster collaboration across life sciences and
healthcare industries, driving strategies that enhance patient
outcomes and sustainable growth. We are proud to bring together
industry leaders to tackle the vital challenge of integrating
patient-centric innovation in today's evolving market through
impactful forums such as Clarivate Pharmavision India."
This year's agenda features insights and perspectives from
industry leaders and analysts, with sessions focused on innovative
R&D, generics, biosimilars and healthcare manufacturing.
Noteworthy sessions include:
- Indian Pharma: Generics versus innovation - finding the
balance for success, by Dr. Keyur
Parekh, President, Corporate Strategy, Zydus Lifesciences
Limited
- The role of AI and big data in healthcare: Transformative
impacts and future prospects, by Mr. Anirban Roy Chowdhury, Senior General Manager,
Amneal Pharmaceuticals
- Cell and gene therapy: Addressing key barriers for
successful integration into clinical practice in the Indian
context, by Dr. Tulip Nuval, Head of Business Excellence, Intas
Pharmaceuticals Limited
- Cell and gene therapy: Addressing key barriers for
successful integration into clinical practice in the Indian
context, by Mr. Rebu Ninan, Head of Commercial & Market
Access, Immuneel Therapeutics Private Limited
- Patients and the LMIC story: How Indian companies drive
affordability in the global scenario, by Dr. Rahul Kapur, Head - Medical Affairs (EM) and
COE, Biocon Biologics Limited
- Creating value for patients and stakeholders, by Mr.
Deepak Sapra, Chief Executive
Officer, API and Services, Dr. Reddy's Laboratories
Pharmavision India takes place on Wednesday, September 25, 2024, at the Hyatt
Ahmedabad, and Thursday, September 26,
2024, at the Taj Deccan, Hyderabad. Register to attend and learn more
on this premier event, here.
Connect with Clarivate Life Sciences and Healthcare. Join the
conversation and mention Clarivate and Pharmavision
on X and LinkedIn. #Pharmavision #PatientCare
#Biopharma #ThinkForward
About Clarivate
Clarivateâ„¢ is a leading global provider of transformative
intelligence. We offer enriched data, insights & analytics,
workflow solutions and expert services in the areas of Academia
& Government, Intellectual Property and Life Sciences &
Healthcare. For more information, please
visit www.clarivate.com
Media Contact:
Catherine Daniel
Director External Communications, Life Sciences &
Healthcare
newsroom@clarivate.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/clarivate-announces-15th-annual-pharmavision-india-conference-agenda-302250677.html
SOURCE Clarivate Plc